journal article·2021-09Open access

A Novel Stimuli‐Responsive Injectable Antibacterial Hydrogel to Achieve Synergetic Photothermal/Gene‐Targeted Therapy towards Uveal Melanoma

Shaoyun Wang, Baohui Chen, Liping Ouyang, Donghui Wang, Ji Tan, Yuqin Qiao, Shengfang Ge, Jing Ruan, Ai Zhuang, Xuanyong Liu, Renbing Jia

Advanced Science· Volume 8· Issue 18

Abstract

Abstract Uveal melanoma (UM) is the most prevalent primary intraocular malignant tumor with a high lethal rate. Patients who undergo conventional enucleation treatments consistently suffer permanent blindness, facial defects, and mental disorders, therefore, novel therapeutic modalities are urgently required. Herein, an injectable and stimuli‐responsive drug delivery antibacterial hydrogel (CP@Au@DC_AC50) is constructed via a facile grinding method that is inspired by the preparation process of traditional Chinese medicine. The incorporation of gold nanorods can enhance the mechanical strength of the hydrogel and realize photothermal therapy (PTT) and thermosensitive gel‐sol transformation to release the gene‐targeted drug DC_AC50 on demand in response to low‐density near‐infrared (NIR) light. The orthotopic model of UM is built successfully and indicates the excellent efficiency of CP@Au@DC_AC50 in killing tumors without damage to normal tissue because of its synergistic mild temperature PTT and gene‐targeted therapy. Moreover, the eyeball infection model reveals the remarkable antibacterial properties of the hydrogel which can prevent endophthalmitis in the eyeball. There is negligible difference between the CP@Au@DC_AC50+NIR group and normal group. This NIR light‐triggered gene‐targeted therapy/PTT/antibacterial treatment pattern provides a promising strategy for building multifunctional therapeutic platform against intraocular tumors and exhibits great potential for the clinical treatment of UM.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Corneal Surgery and Treatments · Ocular Oncology and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Ophthalmology Ninth People's Hospital Shanghai JiaoTong University School of Medicine Shanghai 200025 P. R. China

Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology Shanghai 200025 P. R. China

State Key Laboratory of High Performance Ceramics and Superfine Microstructure Shanghai Institute of Ceramics Chinese Academy of Sciences Shanghai 200050 P. R. China

Center of Materials Science and Optoelectronics Engineering University of Chinese Academy of Sciences Beijing 100049 P. R. China

Cixi Center of Biomaterial Surface Engineering Shanghai Institute of Ceramics Chinese Academy of Sciences Ningbo 315300 P. R. China

School of Chemistry and Materials Science Hangzhou Institute for Advanced Study University of Chinese Academy of Sciences Hangzhou 310024 P. R. China

Funding

National Natural Science Foundation of China · Science and Technology Commission of Shanghai Municipality

References (45)

Show source-provided references
1. 10.1002/cncr.2972710.1002/cncr.29727 ↗
2. 10.1016/j.ajoc.2019.10055710.1016/j.ajoc.2019.100557 ↗
3. 10.3390/ijms2119717210.3390/ijms21197172 ↗
4. 10.1111/j.1365-2354.2009.01073.x10.1111/j.1365-2354.2009.01073.x ↗
5. 10.1016/j.ophtha.2011.01.04010.1016/j.ophtha.2011.01.040 ↗
6. 10.1038/eye.2016.27510.1038/eye.2016.275 ↗
7. 10.1007/978-1-4939-7522-8_1510.1007/978-1-4939-7522-8_15 ↗
8. 10.1124/jpet.119.25693310.1124/jpet.119.256933 ↗
9. 10.1097/APO.000000000000014610.1097/APO.0000000000000146 ↗
10. 10.1002/smll.20200088010.1002/smll.202000880 ↗
11. 10.1016/j.biomaterials.2006.03.02510.1016/j.biomaterials.2006.03.025 ↗
12. 10.1073/pnas.080750610610.1073/pnas.0807506106 ↗
13. 10.1021/acsami.6b0491110.1021/acsami.6b04911 ↗
14. 10.1016/j.biomaterials.2018.09.04510.1016/j.biomaterials.2018.09.045 ↗
15. 10.1016/j.biomaterials.2008.12.08010.1016/j.biomaterials.2008.12.080 ↗
16. 10.1016/j.biomaterials.2018.11.01710.1016/j.biomaterials.2018.11.017 ↗
17. 10.1016/j.biomaterials.2019.04.03110.1016/j.biomaterials.2019.04.031 ↗
18. 10.1002/adfm.20200119610.1002/adfm.202001196 ↗
19. 10.1002/smll.20190004610.1002/smll.201900046 ↗
20. 10.1039/D0BM00391C10.1039/D0BM00391C ↗
21. 10.1002/adhm.20160029210.1002/adhm.201600292 ↗
22. 10.1039/C1CS15203C10.1039/C1CS15203C ↗
23. 10.1038/boneres.2017.1410.1038/boneres.2017.14 ↗
24. 10.1016/j.drudis.2016.07.00610.1016/j.drudis.2016.07.006 ↗
25. 10.3341/kjo.2017.003610.3341/kjo.2017.0036 ↗
26. 10.1159/00043119510.1159/000431195 ↗
27. 10.1126/science.aay918910.1126/science.aay9189 ↗
28. 10.1126/science.aal524010.1126/science.aal5240 ↗
29. 10.1016/j.cell.2018.12.04010.1016/j.cell.2018.12.040 ↗
30. 10.1016/j.cell.2019.07.00810.1016/j.cell.2019.07.008 ↗
31. 10.1016/j.lfs.2003.09.04710.1016/j.lfs.2003.09.047 ↗
32. 10.1016/j.ijpharm.2018.07.03810.1016/j.ijpharm.2018.07.038 ↗
33. 10.1166/jbn.2018.248310.1166/jbn.2018.2483 ↗
34. 10.1016/j.addr.2009.07.01910.1016/j.addr.2009.07.019 ↗
35. 10.1016/j.progpolymsci.2006.06.00110.1016/j.progpolymsci.2006.06.001 ↗
36. 10.1016/j.ijbiomac.2020.03.11210.1016/j.ijbiomac.2020.03.112 ↗
37. 10.1158/1078-0432.CCR-18-338210.1158/1078-0432.CCR-18-3382 ↗
38. 10.1080/1061186X.2018.144040010.1080/1061186X.2018.1440400 ↗
39. 10.1038/nchem.238110.1038/nchem.2381 ↗
40. 10.1002/adfm.20180100010.1002/adfm.201801000 ↗
41. 10.2174/09298670978880331210.2174/092986709788803312 ↗
42. 10.1056/NEJMoa081069910.1056/NEJMoa0810699 ↗
43. 10.1016/j.ejphar.2014.07.02510.1016/j.ejphar.2014.07.025 ↗
44. 10.1186/s12943-019-1088-x10.1186/s12943-019-1088-x ↗
45. 10.1158/1535-7163.MCT-18-066710.1158/1535-7163.MCT-18-0667 ↗